Media Category: Treatments

Biosimilars are becoming increasingly relevant in Multiple Sclerosis (MS) treatment, offering new opportunities for clinical practice. But how can healthcare professionals confidently integrate them into routine care? This e-learning provides practical insights into biosimilar natalizumab, covering regulatory approval, clinical evidence, switching strategies, safety monitoring, and patient communication to support informed treatment decisions. Access the e-learning What does this e-learning include? Expert presentations on the scientific and regulatory foundations of...

Treatment decisions made early in Multiple Sclerosis (MS) may have important implications for long-term neurological outcomes. But how does early high-efficacy treatment compare with traditional escalation strategies? This e-learning examines evidence from clinical trials, international registries and emerging biomarker research. Explore how treatment timing, disease activity and individual risk profiles can inform therapeutic decisions aimed at preserving long-term brain health. Access the e-learning What does this e-learning include? This 1-hour, self-paced course...